Gastrointestinal Cancer Program


The Penn Difference

Innovative Research... Advanced Medicine... Service Excellence

If diagnosed with a GI cancer, or a concern about a GI cancer, it’s important to have the best team of experts available.

At Penn’s Multidisciplinary GI Cancer Program we have individuals nationally recognized for their expertise; who can provide the information, care and support to help each step of the way.

  • Nationally recognized experts with extensive experience in diagnosing and treating gastrointestinal cancers, as well as those at risk
  • Multidisciplinary evaluation
  • Advanced diagnostic testing, treatments and technologies
  • Coordinated care throughout the experience
  • Support services and education programs
  • A reputation for sensitivity and responsiveness
  • Personalized attention
  • Innovative clinical trials
  • The backing of a nationally recognized research program with immediate translation to patient care

What sets Penn's GI Cancer Program apart?

The Abramson Cancer Center's interdisciplinary Gastrointestinal Cancer Program was one of the first of its kind.

Our GI cancer team has dedicated their clinical and research careers to improving our ability to diagnose and treat patients with GI cancer

It is this relentless pursuit for the very best clinical outcome and quality of life that drives Penn's GI Cancer Program.

Founded in 1992, the program is distinguished in a number of ways, including:

  • National experts who have worked together for years in caring for patients with GI cancer as well as those at high risk.
  • Prominent researchers (link to research highlights) who are conducting studies funded by the National Cancer Institute on the causes of GI cancers, risk factors, and treatment advances, thereby ensuring that the latest discoveries are immediately translated to improved patient care.
  • Researchers who are leading the Stand Up 2 Cancer "Dream Team;" one of the most innovative research projects to date, that will accelerate the pace at which new drugs for pancreatic cancer are brought to the patient.
  • A comprehensive range of services that are coordinated for optimal results.
  • Advanced treatments and clinical trials developed by Penn investigators and sponsored by the National Cancer Institute that are available exclusively at Penn or only a few cancer centers.
  • Doctors who led the way in improving patient care by treating GI cancer patients with combined therapies, such as surgery plus chemotherapy or radiation, and new treatments such as photodynamic therapy.
  • Communication with referring physicians.
  • Leading diagnosticians, including GI radiologists and pathologists, whose skills are needed to precisely diagnose GI cancer.
  • Gastroenterologists who are at the forefront of chemoprevention, genetics, diagnosis, staging, and endoscopic therapy, and have made important contributions locally, regionally, and nationally.
  • US News & World Report ranks Penn Gastroenterology as the top in our region and in the top 10 nationally.
  • Gastroenterologists who are specialists in ERCP and EUS and other advanced endoscopic procedures.
  • More than 20,000 endoscopic procedures performed annually by our gastroenterologists.
  • More than 4,000 surgical procedures performed by our gastrointestinal surgeons.
  • 1 ,000 procedures performed annually by our colorectal surgeons. By putting this experience to work, we offer our patients the best possible treatment outcomes.
  • Penn surgeons pioneered methods of treatment and postoperative care that are now used throughout the nation for GI cancer.
  • Surgeons are nationally recognized for conservative procedures, such as laproscopy and sphincter-sparing surgery for rectal cancer.
  • The development of nutritional support standards that are crucial to patient care both during and after treatment.
  • Radiation oncologists who are recognized for techniques that target radiation precisely to the tumor site while sparing normal tissue.